Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Strengthening of the barrier function in human telomerase reverse transcription (hTERT) immortalized corneal and conjunctival epithelium by double-stranded RNA. | Exp Eye Res | 2023 | 36572167 | PubTator, text mining | PubMed |
| Oxymatrine ameliorates white matter injury by modulating gut microbiota after intracerebral hemorrhage in mice. | CNS Neurosci Ther | 2023 | 36550632 | PubTator, text mining | PubMed |
| Molecular weight-dependent hyaluronic acid permeability and tight junction modulation in human buccal TR146 cell monolayers. | Int J Biol Macromol | 2023 | 36529213 | PubTator, text mining | PubMed |
| The utility of claudin-4 versus MOC-31 and Ber-EP4 in the diagnosis of metastatic carcinoma in cytology specimens. | Cancer Cytopathol | 2023 | 36522809 | PubTator, text mining | PubMed |
| An integrative approach for exploring the nature of fibroepithelial neoplasms. | Br J Cancer | 2023 | 36522480 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis. | Virulence | 2023 | 36519347 | PubTator, text mining | PubMed |
| Diagnosis of Metastatic Carcinoma Using Body Cavity Fluid Specimens: A Comparison of Diagnostic Panels. | Acta Cytol | 2023 | 36513033 | PubTator, text mining | PubMed |
| Acute pancreatitis is characterized by generalized intestinal barrier dysfunction in early stage. | Pancreatology | 2023 | 36509643 | PubTator, text mining | PubMed |
| Reconstitution of functional tight junctions with individual claudin subtypes in epithelial cells. | Cell Struct Funct | 2023 | 36504093 | PubTator, text mining | PubMed |
| Leveraging Tissue Engineering for Skin Cancer Models. | Adv Exp Med Biol | 2023 | 36484897 | PubTator, text mining | PubMed |
| Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps. | Clin Exp Allergy | 2023 | 36458367 | PubTator, text mining | PubMed |
| Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells. | JCI Insight | 2023 | 36454643 | PubTator, text mining | PubMed |
| Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling. | Cancer Sci | 2023 | 36441110 | PubTator, text mining | PubMed |
| EpCAM proteolysis and release of complexed claudin-7 repair and maintain the tight junction barrier. | J Cell Biol | 2023 | 36378161 | PubTator, text mining | PubMed |
| Biomolecule-functionalized nanoformulations for prostate cancer theranostics. | J Adv Res | 2023 | 36368516 | PubTator, text mining | PubMed |
| Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors. | Virchows Arch | 2023 | 36348031 | PubTator, text mining | PubMed |
| Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation. | Inflamm Res | 2023 | 36322182 | PubTator, text mining | PubMed |
| Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. | Mol Cancer Res | 2023 | 36306210 | PubTator, text mining | PubMed |
| Plakophilin 2 regulates intestinal barrier function by modulating protein kinase C activity in vitro. | Tissue Barriers | 2023 | 36280901 | PubTator, text mining | PubMed |
| Acute arsenic exposure exacerbates lipopolysaccharide-induced lung injury possibly by compromising the integrity of the lung epithelial barrier in rats. | Sci Total Environ | 2023 | 36265643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=32